Abstract: A combination computer-based information system (CBIS) and computer-implemented method using a mixed-mode/hybrid computer-based operating system in consumer financial services and marketing strategies for providers and consumers using data science(s), reciprocatively Socratic teaching and learning communication methodologies and quantum mechanics is disclosed. The system and method create a digital pathway to inclusion, accelerating branding, and national distribution channels.

Abstract: A combination computer-based information system (CBIS) and computer-implemented method using a mixed-mode/hybrid computer-based operating system in consumer financial services and marketing strategies for providers and consumers using data science(s) and reciprocatively Socratic teaching and learning communication methodologies is disclosed. The system and method create a digital pathway to inclusion, accelerating branding, and national distribution channels.

Abstract: Systems and methods for providing data continuity for a mobile medical cart are provided. A battery board comprising a voltage detection circuit (“VCD”), a microcontroller, and a switching device electrically interposed between an alternative power source, a removable battery, and system boards for controlling cart functions. The microcontroller commands the switching device to: begin sourcing power solely from the alternative power source upon detection of a voltage decrease, begin sourcing power solely from the removable battery upon detection of a voltage increase where a valid charge state exists, and continue sourcing power solely from the alternative power source upon detection of the voltage increase where no valid charge state exists.

Abstract: A combinatorial computer-based information system (CBIS) and computer-implemented method in consumer financial services and marketing strategies for providers and consumers using data science(s) and reciprocate Socratic teaching and learning communication methodologies is disclosed. The system and method create a digital pathway to inclusion, accelerating branding and national distribution channels.

Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.

Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.

Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.

Abstract: A rectangular shaped lockable bin is defined by four walls and a bottom wall. A lid is hingedly mounted to the rear wall and has a slot located in a front portion thereof. A lock having a latch is pivotably mounted to the front wall of said bin at a pivot point and is configured to be selectively rotated between a locked position and an unlocked position by an actuator. A tail extending from the lock contacts a post located on the wall of the bin and basis the lock in the unlocked position. A series of such bins may be received in a delivery module, which may be received in a drawer.

Abstract: The present invention relates to cellobiohydrolase variants, polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of producing and using the variants.

Abstract: The exemplary embodiments herein provide a method for controlling access to medications. The method preferably includes the step of electronically unlocking a lid for a single bin out of a plurality of bins within a delivery module at a first location, to accept a medication into the unlocked bin, where the rest of the bins in the same delivery module remain locked. The method should then engage a mechanical lock on the lid once it has been closed, maintain the bin in a locked state during transport to a second location, and engage a mechanical lock on the delivery module once it has been lowered into a drawer at the second location.

Abstract: The exemplary embodiments herein provide a medical cart having a drawer with a post which extends upwardly from a bottom surface of the drawer. The cart further includes a removable medication delivery module having four sidewalls and a bottom wall as well as a plurality of individually-lockable bins placed above the bottom wall and within the four sidewalls. A lock may be positioned above the bottom wall and below the plurality of individually-lockable bins with an aperture on the lock which engages with the post and a hole in the bottom wall sized to accept the post.

Abstract: The exemplary embodiments herein provide a method for controlling access to medications. The method preferably includes the step of electronically unlocking a lid for a single bin out of a plurality of bins within a delivery module at a first location, to accept a medication into the unlocked bin, where the rest of the bins in the same delivery module remain locked. The method should then engage a mechanical lock on the lid once it has been closed, maintain the bin in a locked state during transport to a second location, and engage a mechanical lock on the delivery module once it has been lowered into a drawer at the second location.

Abstract: A rectangular shaped lockable bin is defined by four walls and a bottom wall. A lid is hingedly mounted to the rear wall and has a slot located in a front portion thereof. A lock having a latch is pivotably mounted to the front wall of said bin at a pivot point and is configured to be selectively rotated between a locked position and an unlocked position by an actuator. A tail extending from the lock contacts a post located on the wall of the bin and basis the lock in the unlocked position. A series of such bins may be received in a delivery module, which may be received in a drawer.

Abstract: The exemplary embodiments herein provide a medical cart having a drawer with a post which extends upwardly from a bottom surface of the drawer. The cart further includes a removable medication delivery module having four sidewalls and a bottom wall as well as a plurality of individually-lockable bins placed above the bottom wall and within the four sidewalls. A lock may be positioned above the bottom wall and below the plurality of individually-lockable bins with an aperture on the lock which engages with the post and a hole in the bottom wall sized to accept the post.

Abstract: The present invention relates to endoglucanase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, expression vectors, and recombinant host cells comprising the polynucleotides; and methods of using the variants.

Abstract: The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.

Abstract: The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.

Abstract: The present invention relates to variants of a parent glycoside hydrolase, comprising a substitution at one or more positions corresponding to positions 21, 94, 157, 205, 206, 247, 337, 350, 373, 383, 438, 455, 467, and 486 of amino acids 1 to 513 of SEQ ID NO: 2, and optionally further comprising a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2 a substitution at one or more positions corresponding to positions 8, 22, 41, 49, 57, 113, 193, 196, 226, 227, 246, 251, 255, 259, 301, 356, 371, 411, and 462 of amino acids 1 to 513 of SEQ ID NO: 2, wherein the variants have glycoside hydrolase activity. The present invention also relates to nucleotide sequences encoding the variant glycoside hydrolases and to nucleic acid constructs, vectors, and host cells comprising the nucleotide sequences.

Abstract: The invention relates to a continuous water monitoring system, including components thereof, and a method relating thereto for continuously monitoring, in real-time, a water supply in order to detect contaminants therein. The system employs the use of a live culture of bioluminescent bacteria and suitable light detecting means.

Abstract: The present invention relates to cellobiohydrolase variants and cellulose binding domain variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.